Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Fulcrum Therapeutics (FULC) Return on Assets (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Return on Assets for 7 consecutive years, with 0.26% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 22.0% to 0.26% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.26% through Dec 2025, down 22.0% year-over-year, with the annual reading at 0.24% for FY2025, 20.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.26% at Fulcrum Therapeutics, up from 0.32% in the prior quarter.
  • The five-year high for Return on Assets was 0.0% in Q1 2025, with the low at 0.5% in Q2 2022.
  • Average Return on Assets over 5 years is 0.32%, with a median of 0.35% recorded in 2023.
  • Peak annual rise in Return on Assets hit 40bps in 2025, while the deepest fall reached -26bps in 2025.
  • Over 5 years, Return on Assets stood at 0.33% in 2021, then tumbled by -40bps to 0.46% in 2022, then increased by 22bps to 0.36% in 2023, then soared by 90bps to 0.04% in 2024, then crashed by -615bps to 0.26% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.26%, 0.32%, and 0.31% for Q4 2025, Q3 2025, and Q2 2025 respectively.